B Group, Inc.
- SEC CIK
- 0002043476
- Latest filing
- Aug 14, 2026
AKRO holding history
Akero Therapeutics, Inc. in every 13F filed by B Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −232,446−100.0% | Sold out | Holders |
| Q3 2025 | 232,446 | $11.0M | 10.6% | 00.0% | Unchanged | Holders |
| Q2 2025 | 232,446 | $12.4M | 10.7% | −10,054−4.1% | Reduced | Holders |
| Q1 2025 | 242,500 | $9.82M | 8.5% | −17,500−6.7% | Reduced | Holders |
| Q4 2024 | 260,000 | $7.23M | 4.4% | – | No prior filing | Holders |